Close
An afternoon of talks on advanced therapeutic approaches, held in 33 Queen Square on Thursday 24th November.
Welcome from Professor Michael Hanna, Director, UCL Queen Square Institute of Neurology
Introduction to the UCL TRO : Dr Pamela Tranter, Head, Translational Research Group
On-demand Cell-autonomous Gene Therapy for Brain Circuit Disorders: Dr Gabriele Lignani, Clinical & Experimental Epilepsy
A Novel Optogenetic Cell Therapy for Amyotrophic Lateral Sclerosis (NOCTALS): Dr Barney Bryson, Department of Neuromuscular Diseases
Introduction to UCL Business: Dr Paolo Spingardi, Business Manager, UCLB
Genetic therapies for Huntington’s disease: challenges and opportunities: Professor Sarah Tabrizi, Director of Huntington's Disease Centre
There and back again? Taking a step towards genetic neuromodulation: Professor Rob Brownstone, Brain Research UK Chair of Neurosurgery
MediaCentral Widget Placeholderhttps://mediacentral.ucl.ac.uk/Player/IcH5ACJ6
Introduction to the UCL technology fund : Dr Tanel Ozdemir
The future of dementia trials: from genetics to treatment: Dr Cath Mummery, Consultant Neurologist at National Hospital, Honorary Associate Professor, UCL Queen Square Institute of Neurology
Brain dystrophin restoration in Duchenne muscular dystrophy: Professor Francesco Muntoni, Chair of Paediatric Neurology, UCL GOS Institute of Child Health & UCL Queen Square Institute of Neurology